MYNXGRIP® Vascular Closure Device

The MYNXGRIP® Closure Device achieves secure extravascular closure by utilizing the GRIP™ sealant, which actively adheres to the artery or vein. The MYNXGRIP® device is also indicated to close femoral venous access sites utilizing a 5F, 6F, or 7F procedural sheath.
Product Description
The MYNXGRIP® Closure Device provides secure mechanical closure with the safety of an extravascular sealant. The MYNXGRIP® device contains the proprietary GRIP™ sealant which actively adheres to and seals the arteriotomy or venotomy while expanding to fill the tissue tract. The MYNXGRIP® device offers a patient-friendly closure option with no cinching, suturing, or metal implants. The GRIP™ sealant dissolves within 30 days leaving nothing permanently behind but a healed artery. 

Secure Extravascular Closure

Deploy the Balloon
Achieve temporary hemostasis at the arteriotomy.

Place the Sealant
The Grip Technology sealant effectively grips the artery and provides secure extravascular closure.

Remove the Device
Deflate the balloon and remove the device, leaving nothing behind but a healed artery. The sealant resorbs within 30 days.

Refer to the IFU for detailed procedure steps

The MYNXGRIP® Vascular Closure Device is manufactured by Cardinal Health and is part of the Cordis portfolio.

Clinical Resources


Clinical Articles

Mynx Vascular Closure Device Achieves Reliable Closure and Hemostasis of Percutaneous Transfemoral Venous Access in a Porcine Vascular Model
S. Sanjay Srivatsa, MBBChir1; Arjun Srivatsa1; Taylor A. Spangler, DVM, DACVP2. The Journal of Invasive Cardiology. February 2015.

The MYNXGRIP® Vascular Closure Device
Hoang Minh Thai, MD, FACC, FSCAI, and Barry S. Weinstock, MD. Endovascular Today. April 2012.

Successful Reduction of Surgeries Secondary to Arterial Access Site Complications
A Retrospective Review at a Single-Center with an Extravascular Closure Device.
Noor S, Meyers S, Curl R. Vascular and Endovascular Surgery. May 2010;44(5):345-9.

A Prospective Randomized Single-blind trial of Patient Comfort Following Vessel Closure
Extravascular Synthetic Sealant Closure Provides Less Pain than a Self-tightening Suture Vascular Compression Device.
Fargen KM, Hoh BL, Mocco J. J Neurointerv Surg. 2011;3(3):219-23.

Mynx Vascular Closure Device Early Ambulation Study
Vikranth R. Gongidi, DO; Ahsan Jafir, DO; and Vijay Verma, MD, FACC, FSCAI. Endovascular Today. October 2013.

Occurrence of angiographic femoral artery complications after vascular closure with Mynx and AngioSeal
Fargen KM, Velat GJ, Lawson MF, et al. Journal of Neurolnterventional Surgery. 2013;5(2):161-4.

Use of Vascular Closure Device After Access of Common Femoral Artery Through an Existing Stent
George JC. Vascular Disease Management. 2012;9(5):E68-E70.

Two Years of Extravascular Closure With the Mynx® Vascular Closure Device
The Baptist Memorial Hospital experience revisited.
David Wolford, MD, FACC. Endovascular Today. August 2010.

Mynx Closure in a Patient Treated for Chronic Total Occlusion of the Iliac Artery with Multiple Sheath Exchanges.
A Case Review. Michael S. Fenster, MD. TCTMD. May 2009.

Why Extravascular Closure?
The Baptist Memorial Hospital Experience with the Mynx Vascular Closure Device.
David Wolford, MD, FACC. Endovascular Today. August 2009.

The Safety and Efficacy of an Extravascular, Water-Soluble Sealant for Vascular Closure
Initial Clinical Results for Mynx. D. Scheinert MD et al. Catheterization and Cardiovascular Interventions. November 2007.